Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05722366
Other study ID # DokuzEU-CAD-001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 20, 2022
Est. completion date August 1, 2023

Study information

Verified date September 2023
Source Dokuz Eylul University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

At least 25 volunteers with a diagnosis of coronary artery disease in the Department of Cardiology of Dokuz Eylul University and who meet the criteria for follow-up and inclusion will participate in the study. Demographic and clinical information of the participants will be questioned. Active video games and exercise sessions will be randomized to last 25 minutes. Before and after the sessions, heart rate, blood pressure, shortness of breath, oxygen saturation and arterial stiffness will be measured. In addition, energy expenditure, heart rate, perceived exertion, shortness of breath and oxygen saturation will be recorded during the sessions. At the end of the sessions, the person will be asked if they enjoy active video games.


Description:

Individuals etiology, demographic information (age, gender,marital status, education,occupation),risk factors (smoking,alcohol use,exercise habit),height,weight,curriculum vitae, family history, medications used, and effort test results will be recorded. Evaluation of energy expenditure: Energy expenditure during active video games and exercise will be evaluated using the activity monitor. The activity monitor will be attached to the upper arm. Its accelerometer measures skin temperature, galvanic skin response and heat flux, as well as energy expenditure during movement. Evaluation of hemodynamic and pulmonary responses: Blood pressure: It will be measured with a sphygmomanometer. Perceived effort: The degree of perceived effort will be evaluated with the Modified Borg scale. Shortness of breath: Shortness of breath will be assessed with the Modified Borg scale. Heart rate and Oxygen saturation: It will be evaluated by pulse oximetry. Evaluation of vascular responses: Arterial stiffness will be assessed to assess vascular responses to active video games and exercise. Arterial stiffness will be measured with a noninvasive method with the help of the SphygmocorXCEL device, which can automatically measure with the cuff. The patient's age, gender, blood pressure, height, weight, carotid-sternal notch distance between the artery, carotid-femoral artery as the distance between the entered data to the computer after increasing pressure over the brachial artery through a transducer (augmentation index) and again, carotid-femoral pulse wave velocity via the artery (pulse wave velocity) measurements will be made. The pleasure received from both interventions will be evaluated according to the visual analogue scale (0-10). Active Video Game Intervention The active video games intervention will be carried out with a virtual reality system (XBOX360, Microsoft, USA) consisting of a console and a sensor. Active video games consist of Bowling, River Rush, Rally Ball and Reflex Ridge games. Participants will exercise for a total of 25 minutes with light-paced games for warm-up for the first 5 minutes, then brisk games with different body movements until the 15 minutes are complete, and light-paced games for 5 minutes to cool down. Participants will complete active video games in the same order. Aerobic Exercise Intervention The exercise intervention will consist of a continuous moderate-intensity walking session on the treadmill. After the first 5 minutes of warm-up, at 55-70% of the peak heart rate reserve(HRR)with a 15-minute walking session, and 5 minutes of cooling down a total of 25 minutes of exercise will be performed. Blood pressure, heart rate, oxygen saturation, dyspnea, and perceived general fatigue (Mod.Borg 0-10) of the participants will be evaluated before the interventions, at the end of the loading, after the exercise, and 5 minutes after the intervention. Before and after the sessions arterial stiffness will be measured.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date August 1, 2023
Est. primary completion date April 14, 2023
Accepts healthy volunteers No
Gender Male
Age group 40 Years to 75 Years
Eligibility Inclusion Criteria: - Having been diagnosed with coronary artery disease - Being clinically stable - Becoming a volunteer Exclusion Criteria: - The presence of unstable angina - The presence of a pacemaker - The presence of cardiomyopathy - The presence of a high cardiovascular risk - The presence of November severe neurological, pulmonary and musculoskeletal system diseases - The patient wants to quit the study

Study Design


Intervention

Other:
Active video game
With the closed envelope method, the order in which the participants will perform active video games and aerobic exercise will be determined. It will be applied with 2 weeks between interventions.
aerobic exercise
With the closed envelope method, the order in which the participants will perform active video games and aerobic exercise will be determined. It will be applied with 2 weeks between interventions.

Locations

Country Name City State
Turkey Dokuz Eylül University Izmir Balcova

Sponsors (1)

Lead Sponsor Collaborator
Dokuz Eylul University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Exercise load end heart rate It will be measured with a pulse oximeter at the end of 15 minutes of exercise loading after warming up. At the 15th minute of the exercise after the warm-up.
Primary Exercise load end blood pressure It will be measured with a sphygmomanometer at the end of 15 minutes of exercise loading after warming up. At the 15th minute of the exercise after the warm-up.
Primary Exercise load end perceived effort The degree of perceived effort will be evaluated with the modified borg scale (M.Borg 0-10)at the end of 15 minutes of exercise loading after warming up. As the modified borg score of the person increases, the perceived effort will increase. At the 15th minute of the exercise after the warm-up.
Primary Exercise load end oxygen saturation Oxygen saturation will be evaluated by pulse oximetry at the end of 15 minutes of exercise loading after warming up. At the 15th minute of the exercise after the warm-up.
Primary Exercise load end shortness of breath Shortness of breath will be assessed with the modified borg scale(M.Borg 0-10) at the end of 15 minutes of exercise loading after warming up.As the modified borg score of the person increases, the perceived shortness of breath will increase. At the 15th minute of the exercise after the warm-up.
Secondary Evaluation of energy expenditure Energy expenditure during active video games and exercise will be evaluated using the activity monitor. The activity monitor will be attached to the upper arm. Its accelerometer measures skin temperature, galvanic skin response and heat flux, as well as energy expenditure during movement. ''During exercise intervention, average 25 minutes''
Secondary Evaluation of Arterial stiffness Arterial stiffness will be measured with a noninvasive method with the help of the SphygmocorXCEL device, which can automatically measure with the cuff. By means of a transducer, the pressure on the brachial artery will be increased (augmentation index) and carotid-femoral pulse wave velocity (pulse wave velocity) measurements will be made over the artery. Before interventions
Secondary Evaluation of Arterial stiffness Arterial stiffness will be measured with a noninvasive method with the help of the SphygmocorXCEL device, which can automatically measure with the cuff. By means of a transducer, the pressure on the brachial artery will be increased (augmentation index) and carotid-femoral pulse wave velocity (pulse wave velocity) measurements will be made over the artery. ''First minutes'' after the intervention
Secondary Baseline Blood pressure Systolic and diastolic blood pressure will be measured with a sphygmomanometer. Before interventions
Secondary End of intervention blood pressure Systolic and diastolic blood pressure will be measured with a sphygmomanometer. Within the first minutes after the intervention
Secondary Evaluation blood pressure Systolic and diastolic blood pressure will be measured with a sphygmomanometer. 5 minutes after exercises
Secondary Baseline heart rate Heart rate will be evaluated by pulse oximetry. Before interventions
Secondary End of intervention heart rate Heart rate will be evaluated by pulse oximetry. ''First minutes'' after the intervention
Secondary Evaluation heart rate Heart rate will be evaluated by pulse oximetry. 5 minutes after exercises
Secondary Baseline perceived effort The degree of perceived effort will be evaluated with the Modified Borg scale(M.Borg 0-10).As the modified borg score of the person increases, the perceived effort will increase. Before interventions
Secondary End of intervention perceived effort The degree of perceived effort will be evaluated with the Modified Borg scale(M.Borg).As the modified borg score of the person increases, the perceived effort will increase. Within the first minutes after the intervention
Secondary Evaluation perceived effort The degree of perceived effort will be evaluated with the Modified Borg scale(M.Borg).As the modified borg score of the person increases, the perceived effort will increase. 5 minutes after exercises
Secondary Baseline Shortness of breath Shortness of breath will be assessed with the Modified Borg scale(M.Borg).As the modified borg score of the person increases, the perceived shortness of breath will increase. Before interventions
Secondary End of intervention Shortness of breath Shortness of breath will be assessed with the Modified Borg scale(M.Borg).As the modified borg score of the person increases, the perceived shortness of breath will increase. ''First minutes'' after the intervention
Secondary Evaluation Shortness of breath Shortness of breath will be assessed with the Modified Borg scale(M.Borg).As the modified borg score of the person increases, the perceived shortness of breath will increase. 5 minutes after exercises
Secondary Baseline Oxygen saturation Oxygen saturation will be evaluated by pulse oximetry. Before interventions
Secondary End of Oxygen saturation Oxygen saturation will be evaluated by pulse oximetry. ''First minutes'' after the intervention
Secondary Evaluation Oxygen saturation Oxygen saturation will be evaluated by pulse oximetry. 5 minutes after exercises
Secondary Enjoyment of interventions The enjoyment received from both interventions will be evaluated according to the visual analogue scale (0-10).As the visual analog scale score increases, the person's satisfaction with the exercise increases. 5 minutes after interventions
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A